TC BioPharm (Holdings) Income Statement 2020-2024 | TCBP

Fifteen years of historical annual and quarterly income statements for TC BioPharm (Holdings) (TCBP).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM2023202220212020
$0.00$0$4.76$2.72$0
$0.00$0$0$0$0
$0.00$0$4.76$2.72$0
$1.65$9.67$9.21$8.47$0
$2.72$8.05$10.29$4.27$0
$0.00$-0.10$-0.15$-0.11$0
$0.00$0$0$0$0
$-4.36$-17.81$-14.89$-10.13$0
$0.00$9.11$11.05$-10.48$0
$-4.35$-8.70$-3.85$-20.60$0
$-0.14$-1.35$-2.13$-1.94$0
$-4.21$-7.35$-1.72$-18.67$0
$0.00$0$0$0$0
$-4.21$-7.35$-1.72$-18.67$0
$0.00$0$0$0$0
$-4.21$-7.35$-1.72$-18.67$0
$-4.20$-17.02$-13.94$-8.99$0
$-4.36$-17.81$-14.89$-10.13$0
$-27.95$-11.94$-499.71$-9,626.00$0
$-27.95$-11.94$-499.71$-9,626.00$0.00

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-03-312023-12-312023-06-302022-12-312022-06-302021-12-31
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$1.65$0$0$0$0$0
$2.72$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$-4.36$0$0$0$0$0
$0.00$0$0$0$0$0
$-4.35$0$0$0$0$0
$-0.14$0$0$0$0$0
$-4.21$0$0$0$0$0
$0$0$0$0$0$0
$-4.21$0$0$0$0$0
$0$0$0$0$0$0
$-4.21$0$0$0$0$0
$-4.20$0$0$0$0$0
$-4.36$0$0$0$0$0
$-27.95$0$0$0$0$0
$-27.95$0.00$0.00$0.00$0.00$0.00